Year to date, Nuvalent’s shares have surged 42.4% compared with the industry’s 1.0% growth. During this timeframe, the stock has also outperformed the sector and the S&P 500.

Shares of the biotech Nuvalent were up sharply early Monday, after the company unveiled updates on two experimental cancer ...

On Friday, Nuvalent Inc (NUVL) stock saw a modest uptick, ending the day at $89.22 which represents a slight increase of $0.73 or 0.82% from the prior close of $88.49. The stock opened at $89 and ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the ...

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the stock, Marketbeat reports.

UBS initiated coverage of Nuvalent (NUVL) with a Neutral rating and $100 price target The firm launched coverage of SMID cap biotech sector with a focus in oncology and autoimmune diseases.

UBS Group began coverage on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $100. ...

Try Now>> See the top stocks recommended by analysts >> Read More on NUVL: Nuvalent NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Top-performing mid-cap stocks last week. Nuvalent shares are trading lower by 6.2% during Tuesday's session. The company priced a $500 million public offering of 5 million shares at $100 each.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nuvalent, Inc. (NASDAQ:NUVL) has reported a series of transactions involving its Chief Development Officer, Darlene Noci, according to the latest SEC filings. On October 1, Noci engaged in both ...

Traders use this information to analyze potential trades and assess market sentiment for Nuvalent. In The Money Expiration Date November 15, 2024 December 20, 2024 January 17, 2025 April 17, 2025 ...